beta

ALC

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap:

Primary Exchange:

Website: /stocks/alc

Shares Outstanding:

Float:

Dividend: (%)

Beta:

Sector:

Industry:

Short Interest ():

Ethical Flags

Longest drawdown: 46 trading days

From: 2019-04-09 To: 2019-04-18

Lowest Point:

Novartis: Look To Alcon Instead

via: SeekingAlpha at 2019-04-16 05:22:20:000

Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...

Novartis: Look To Alcon Instead

via: SeekingAlpha at 2019-04-16 05:22:20:000

Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...

Novartis: Look To Alcon Instead

via: SeekingAlpha at 2019-04-16 05:22:20:000

Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...

Novartis: Look To Alcon Instead

via: SeekingAlpha at 2019-04-16 05:22:20:000

Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...

Novartis: Look To Alcon Instead

via: SeekingAlpha at 2019-04-16 05:22:20:000

Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...

Novartis: Look To Alcon Instead

via: SeekingAlpha at 2019-04-16 05:22:20:000

Investment Summary Investors got excited over the prospect of Novartis ( NVS ) becoming a super-scale biotech company following the spin-off of their eye care device segment Alcon ( ALC ). However, the recent run-up in NVS's share price implies a strong pipeline execution and may be sub… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX